Author(s): Fein AM, CalalangColucci MG
Abstract Share this page
Abstract Sepsis remains the leading cause of ARDS, and ARDS is still an often fatal condition. With our expanding knowledge of the pathobiologic mechanisms and the relationship between these two entities, early recognition, treatment, and prevention of sepsis may prevent or hasten recovery from ARDS. Understanding the biologic markers involved in the complex inflammatory response of sepsis and acute lung injury offers the possibility of future investigations to target treatment based on these mediators.
This article was published in Crit Care Clin
and referenced in Journal of Clinical Toxicology